A case of image-guided hematometrocolpos drainage requiring tissue plasminogen activator in a pediatric patient. [PDF]
Sharma P, Shah J, Sokkary N.
europepmc +1 more source
Functional, pathogenic, and pharmacological roles of protein folding intermediates
Abstract Protein expression and function in eukaryotic cells are tightly harmonized processes modulated by the combination of different layers of regulation, including transcription, processing, stability, and translation of messenger RNA, as well as assembly, maturation, sorting, recycling, and degradation of polypeptides.
Emiliano Biasini, Pietro Faccioli
wiley +1 more source
Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation. [PDF]
Seillier C+7 more
europepmc +1 more source
Traditional Chinese medicine in atherosclerosis: multi‐target modulation of pathogenesis. ABSTRACT Atherosclerosis is a chronic inflammatory disease and a major global health concern. In recent years, traditional Chinese medicines (TCMs) have demonstrated multi‐target therapeutic potential against atherosclerosis by modulating inflammatory responses ...
Dilaram Nijat+5 more
wiley +1 more source
The reperfusion rates after recombinant human tissue plasminogen activator thrombolysis depend not on a few but on a plethora of influencing factors. [PDF]
Finsterer J, Scorza FA, Scorza CA.
europepmc +1 more source
Micro‐ and nanomotors in biomedical applications
Micro‐ and nanomotors (MNMs), as autonomous devices converting chemical or external energy into mechanical propulsion, have emerged as transformative drug delivery platforms in biomedicine. This review systematically outlines the design principles governing MNMs' propulsion and operation, highlights the applications of MNMs in disease treatment, and ...
Xiangyu Meng, Yuqi Tang, Quan Li
wiley +1 more source
The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer's disease: a new perspective. [PDF]
Ali NH+7 more
europepmc +1 more source
Revisiting the Link Between Factor XII and Recurrent Pregnancy Loss: A Scoping Review
ABSTRACT Pregnancy loss affects approximately 23% of women, with 1%–3% experiencing recurrent pregnancy loss (RPL), defined as two or more consecutive miscarriages. Despite extensive research, up to 50% of RPL cases remain unexplained, making it a complex issue in reproductive medicine.
Emma Bundgaard+3 more
wiley +1 more source
Effects of Combination Therapy with Intravitreal Ranibizumab and Tissue Plasminogen Activator for Neovascular Age-Related Macular Degeneration. [PDF]
Ando M+11 more
europepmc +1 more source
Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): update to study protocol and addition of a statistical analysis plan and health economic analysis plan for a randomised controlled surgical trial. [PDF]
Lee CN+15 more
europepmc +1 more source